274 related articles for article (PubMed ID: 15973553)
1. American society of clinical oncology--41st annual meeting.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
[No Abstract] [Full Text] [Related]
2. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
[No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology--41st annual meeting. Drug highlights I.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):531-3. PubMed ID: 15973555
[No Abstract] [Full Text] [Related]
4. American society of clinical oncology--41st annual meeting. Immunology.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
[No Abstract] [Full Text] [Related]
5. American society of clinical oncology - 45th annual meeting. Part 2.
Lakeram M; Kibble A
IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
[No Abstract] [Full Text] [Related]
6. American society of clinical oncology - 45th annual meeting. Part 1.
Gale S
IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
[No Abstract] [Full Text] [Related]
7. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Morgensztern D; Pennell NA; Subramanian J; Govindan R
Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
9. [ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].
Höhler T; Heike M; Lutz MP; Graeven U; Seufferlein T;
Z Gastroenterol; 2005 Nov; 43(11):1253-9. PubMed ID: 16267711
[TBL] [Abstract][Full Text] [Related]
10. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
Montemurro F; Valabrega G; Garetto L; Aliberti S; Grignani G; Ortega C; Leone F; Ponzone R; Aglietta M
Expert Opin Pharmacother; 2005 Dec; 6(16):2907-21. PubMed ID: 16318441
[TBL] [Abstract][Full Text] [Related]
11. Highlights from the 41st Annual Meeting of the American Society of Clinical Oncology, May 2005, and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, February 2005, Orlando, Florida.
Reddy GK; Tyagi P
Clin Prostate Cancer; 2005 Jun; 4(1):7-14. PubMed ID: 15992456
[No Abstract] [Full Text] [Related]
12. New scale assesses benefits of cancer medicines.
Bagcchi S
Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
[No Abstract] [Full Text] [Related]
13. 2015 ASCO Annual Meeting.
Coburn C
Lancet Oncol; 2015 Jul; 16(7):755-6. PubMed ID: 26062778
[No Abstract] [Full Text] [Related]
14. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
[No Abstract] [Full Text] [Related]
15. 2020 ASCO Virtual Annual Meeting.
Collingridge D
Lancet Oncol; 2020 Jul; 21(7):885-886. PubMed ID: 32511985
[No Abstract] [Full Text] [Related]
16. Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency.
Cunanan KM; Gonen M; Shen R; Hyman DM; Riely GJ; Begg CB; Iasonos A
J Clin Oncol; 2017 Jan; 35(3):271-273. PubMed ID: 27893325
[No Abstract] [Full Text] [Related]
17. Targeted drugs take centre stage at US cancer meeting.
McCarthy M
Lancet; 2001 May; 357(9268):1593. PubMed ID: 11377652
[No Abstract] [Full Text] [Related]
18. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 1.
Searle B
IDrugs; 2008 Aug; 11(8):545-6. PubMed ID: 18683083
[No Abstract] [Full Text] [Related]
19. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Oberstein PE; Saif MW
JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 2.
Ogbighele E
IDrugs; 2008 Aug; 11(8):547-9. PubMed ID: 18683084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
